GS Investments’s Bio-Techne TECH Stock Holding History

GS Investments’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-80	Closed	-$5.93K	–	151
2023 Q1	$5.93K	Hold	80	–	–	﹤0.01%	123
2022 Q4	$6.63K	Hold	80	–	–	﹤0.01%	120
2022 Q3	$6K	Hold	80	–	–	﹤0.01%	120
2022 Q2	$8K	Hold	80	–	–	﹤0.01%	123
2022 Q1	$8K	Hold	80	–	–	﹤0.01%	123
2021 Q4	$10K	Hold	80	–	–	﹤0.01%	120
2021 Q3	$10K	Hold	80	–	–	0.01%	117
2021 Q2	$9K	Hold	80	–	–	0.01%	58
2021 Q1	$8K	Hold	80	–	–	0.02%	53
2020 Q4	$6K	Hold	80	–	–	0.01%	110
2020 Q3	$5K	Hold	80	–	–	0.01%	53
2020 Q2	$5.28K	Hold	80	–	–	﹤0.01%	97
2020 Q1	$3.79K	Hold	80	–	–	﹤0.01%	97
2019 Q4	$2.96K	Hold	80	–	–	﹤0.01%	111
2019 Q3	$3.91K	Hold	80	–	–	﹤0.01%	106
2019 Q2	$4.17K	Hold	80	–	–	﹤0.01%	106
2019 Q1	$3.97K	Hold	80	–	–	﹤0.01%	107
2018 Q4	$2.89K	Hold	80	–	–	﹤0.01%	114
2018 Q3	$4.08K	Hold	80	–	–	﹤0.01%	112
2018 Q2	$2.96K	Sell	80 -52	-39%	-$1.99K	﹤0.01%	117
2018 Q1	$4.98K	Buy	+132	New	+$4.66K	﹤0.01%	106

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

GS Investments's TECH Position: Q2 2023 in Review

GS Investments sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 80 shares — an estimated $5.93K sold.

GS Investments first reported a position in TECH in Q1 2018 and held it in 21 quarters. The position peaked at $10K in Q4 2021. 529 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

GS Investments reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
GS Investments sold 80 Bio-Techne shares in Q2 2023, an estimated $5.93K.
GS Investments first reported a position in Bio-Techne in Q1 2018 and held it in 21 quarters.
GS Investments's Bio-Techne position peaked at $10K in Q4 2021.
529 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on GS Investments's 13F filing for Q2 2023, filed 4 Aug 2023.